#ASO in episode #S10e80: https://youtu.be/xeo94GViXiw?t=240
I am #StokedAboutStoke 
BW Press Release with Link to their presentation: https://www.businesswire.com/news/home/20221114005268/en/Stoke-Therapeutics-Reports-Third-Quarter-Financial-Results-and-Provides-Business-Updates
Stoke announced partnership with Acadia in Episode 43 of Syngap10… https://www.youtube.com/watch?v=jElXobgYfCQ
 
Register for our meeting on December 1 in Nashville: 
https://secure.givelively.org/event/syngap-research-fund-incorporated/syngap1-conference-2022-charting-our-rare-disease-treatment-path 
 
Further reading:
- STOK Stock https://www.google.com/finance/quote/STOK:NASDAQ?window=1M
- Recent paper on ASOs: https://www.karger.com/Article/Pdf/517686
- Dr. Kimberly Parkerson of Stoke Therapeutics offers an update on their BUTTERFLY observational study as well as their MONARCH and SWALLOWTAIL studies https://www.youtube.com/watch?v=xHCYFDSwf-o
 
This is a podcast: subscribe to and rate this 10 minute #podcast #SYNGAP10 here https://www.syngapresearchfund.org/syngap10-podcast 
Apple podcasts: https://syngap.fund/10a
 
Episode 83 of #Syngap10 - November 22,  2022 
 
#Syngap #SYNGAP1 #epilepsy #autism #intellectualdisability #id #anxiety #raredisease #epilepsyawareness #autismawareness #rarediseaseresearch #SynGAPResearchFund #CareAboutRare #PatientAdvocacy #GCchat #Neurology